Artemotil

Artemotil

Clinical data
Pregnancy category	not available
Routes of administration	Intramuscular injection
ATC code	P01BE04 (WHO)
Pharmacokinetic data
Metabolism	Hepatic
Elimination half-life	20 hours
Identifiers
CAS Number	109716-83-8
PubChem CID	72416
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C17H28O5
Molar mass	312.401 g/mol

WikiDoc Resources for Artemotil
Articles
Most recent articles on Artemotil Most cited articles on Artemotil Review articles on Artemotil Articles on Artemotil in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Artemotil Images of Artemotil Photos of Artemotil Podcasts & MP3s on Artemotil Videos on Artemotil
Evidence Based Medicine
Cochrane Collaboration on Artemotil Bandolier on Artemotil TRIP on Artemotil
Clinical Trials
Ongoing Trials on Artemotil at Clinical Trials.gov Trial results on Artemotil Clinical Trials on Artemotil at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Artemotil NICE Guidance on Artemotil NHS PRODIGY Guidance FDA on Artemotil CDC on Artemotil
Books
Books on Artemotil
News
Artemotil in the news Be alerted to news on Artemotil News trends on Artemotil
Commentary
Blogs on Artemotil
Definitions
Definitions of Artemotil
Patient Resources / Community
Patient resources on Artemotil Discussion groups on Artemotil Patient Handouts on Artemotil Directions to Hospitals Treating Artemotil Risk calculators and risk factors for Artemotil
Healthcare Provider Resources
Symptoms of Artemotil Causes & Risk Factors for Artemotil Diagnostic studies for Artemotil Treatment of Artemotil
Continuing Medical Education (CME)
CME Programs on Artemotil
International
Artemotil en Espanol Artemotil en Francais
Business
Artemotil in the Marketplace Patents on Artemotil
Experimental / Informatics
List of terms related to Artemotil

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Artemotil (INN; also known as arteether or α/β arteether, trade name Rapither AB), is a fast acting blood schizontocide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria cases. It is a semi-synthetic derivative of artemisinin, a natural product of the Chinese plant Artemisia annua. It is currently only used as a second line drug in severe cases of malaria.